ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine

C26H28N8 — CID 164537166

IUPACethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine
SMILESCC.c1cc(NC2CC3(CNC3)C2)nc(-c2cnc3ccc(-c4cnn5ccccc45)nn23)c1
InChIInChI=1S/C24H22N8.C2H6/c1-2-9-31-20(5-1)17(12-27-31)18-7-8-23-26-13-21(32(23)30-18)19-4-3-6-22(29-19)28-16-10-24(11-16)14-25-15-24;1-2/h1-9,12-13,16,25H,10-11,14-15H2,(H,28,29);1-2H3
InChIKeyJTKFJHGSYDEUJL-UHFFFAOYSA-N
MW452.57 g/mol
LogP4.30
Rot. Bonds4

About ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine

ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine (PubChem CID 164537166) has the molecular formula C26H28N8 and a molecular weight of 452.57 g/mol. Its IUPAC name is ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine.

Molecular Properties

Compound Nameethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine
PubChem CID164537166
Molecular FormulaC26H28N8
Molecular Weight452.57 g/mol
Exact Mass452.24
IUPAC Nameethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine
SMILESCC.c1cc(NC2CC3(CNC3)C2)nc(-c2cnc3ccc(-c4cnn5ccccc45)nn23)c1
InChIInChI=1S/C24H22N8.C2H6/c1-2-9-31-20(5-1)17(12-27-31)18-7-8-23-26-13-21(32(23)30-18)19-4-3-6-22(29-19)28-16-10-24(11-16)14-25-15-24;1-2/h1-9,12-13,16,25H,10-11,14-15H2,(H,28,29);1-2H3
InChIKeyJTKFJHGSYDEUJL-UHFFFAOYSA-N
XLogP4.30
TPSA84.44 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500452.57
LogP ≤ 54.30
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine?
The IUPAC name of ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine (CID 164537166) is ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine.
What is the SMILES notation for ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine?
The canonical SMILES for ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine is CC.c1cc(NC2CC3(CNC3)C2)nc(-c2cnc3ccc(-c4cnn5ccccc45)nn23)c1.
What is the InChIKey of ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine?
The InChIKey is JTKFJHGSYDEUJL-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22N8.C2H6/c1-2-9-31-20(5-1)17(12-27-31)18-7-8-23-26-13-21(32(23)30-18)19-4-3-6-22(29-19)28-16-10-24(11-16)14-25-15-24;1-2/h1-9,12-13,16,25H,10-11,14-15H2,(H,28,29);1-2H3.
What are the key properties of ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine?
ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine has a molecular weight of 452.57 g/mol, XLogP of 4.30, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for ethane;N-[6-(6-pyrazolo[1,5-a]pyridin-3-ylimidazo[1,2-b]pyridazin-3-yl)-2-pyridinyl]-2-azaspiro[3.3]heptan-6-amine is sourced from PubChem (CID 164537166), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).